Nykode Therapeutics

Nykode

Nykode develops immunotherapy and vaccines for cancer and infectious diseases, targeting pharmaceutical companies through partnerships and licensing agreements.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Nurix Therapeutics

This company develops targeted protein degradation therapies to treat patients with cancer and autoimmune diseases.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Vaccitech Ltd

This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.

immunique

This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.

Hubro Therapeutics

This company develops neoantigen-targeted cancer vaccines for patients with gastrointestinal cancers to activate anti-cancer specific T-cell immune responses.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.